Activating β-catenin/Pax6 axis negatively regulates osteoclastogenesis by selectively inhibiting phosphorylation of p38/MAPK.
Jie Z, Shen S, Zhao X, Xu W, Zhang X, Huang B, Tang P, Qin A, Fan S, Xie Z.
Jie Z, et al. Among authors: xu w.
FASEB J. 2019 Mar;33(3):4236-4247. doi: 10.1096/fj.201801977R. Epub 2018 Dec 7.
FASEB J. 2019.
PMID: 30526042
In addition, our study proposes a novel approach to treat osteoclast-related diseases through the use of VX-745 complemented with the beta-catenin activator SKL2001.-Jie, Z., Shen, S., Zhao, X., Xu, W., Zhang, X., Huang, B., Tang, P., Qin, A., Fan, S., Xie, Z. Activ …
In addition, our study proposes a novel approach to treat osteoclast-related diseases through the use of VX-745 complemented with the beta-c …